Cellectis Appoints Biopharma Veteran Leopold Bertea as Senior Vice President of Technical Operations – Europe

NEXT STORY
Turning Point Therapeutics Announces Pricing of $325 Million Public Offering of Common Stock
PREV STORY
Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for Fourth Fiscal Quarter and Full Fiscal Year Ended March 31, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

U.S. Endoscopy Devices Market Report 2021, Featuring Key Players Boston Scientific, Medtronic, Johnson and Johnson, Stryker and CONMED

author_avatar
NASDAQ Market News

Paratek’s NUZYRA™ (omadacycline) Generates Net Sales of $1.3 Million in the First Eight Weeks on the U.S. Market

author_avatar
NASDAQ Market News

KESSLER TOPAZ MELTZER & CHECK, LLP:  Final Deadline Reminder for CHEMBIO DIAGNOSTICS, INC. Investors – CEMI

author_avatar
NASDAQ Market News